Introduction: A 4-layer proximity assay model compares 5 target-engagement signals and 3 translation-risk tiers across molecular glue, RIPTAC, and tri-complex programs. Proximity pharmacology has outgrown the assumption that every induced interaction should end in protein degradation. Molecular glues can stabilize a protein interaction and redirect recognition. RIPTAC programs can exploit a ternary complex to change a cellular function or survival state without making degradation the primary biological objective. Tri-complex systems may use an additional component to control assembly, localization, or signal output. These mechanisms demand assay designs that measure the intended consequence of proximity rather than applying a degradation template by default. That distinction changes assay selection, data interpretation, and translation planning. This article presents a four-layer evidence architecture and a modality decision matrix for evaluating CRO support in proximity pharmacology...
Welcome to Cross-Border Chronicles, your go-to place for everything about cross-border sourcing, international trade, and global manufacturing. Here, we dive into the world of global supply chains, unpack market trends, and share practical insights to help businesses navigate the complexities of international sourcing. From managing suppliers to understanding tariffs, from market entry strategies to manufacturing tips—we’ve got you covered.